Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/7/2025

Urinary Tract Infection Management

Diagnostic Approach

  • The European Urology guidelines recommend that for uncomplicated UTIs in otherwise healthy, non-pregnant women with no anatomical abnormalities, first-line oral antibiotics (nitrofurantoin, trimethoprim-sulfamethoxazole, or fosfomycin) should be used for 3-7 days without routine imaging 1, 2
  • For women with typical symptoms (dysuria, frequency, urgency) and no vaginal discharge, clinical diagnosis alone is sufficient, with dysuria having >90% accuracy for UTI 3, 1, 4
  • Urine culture is NOT routinely needed for initial uncomplicated cystitis, but should be obtained if suspected pyelonephritis, symptoms persist or recur within 4 weeks, atypical presentation, pregnancy, or recurrent UTIs (≥3 episodes in 12 months) 1, 2, 3, 6

Treatment Algorithm

  • The European Urology guidelines recommend using the shortest effective duration of antibiotics, generally 3-7 days maximum, for uncomplicated UTI 6, 1
  • First-line options for uncomplicated UTI include nitrofurantoin 100 mg twice daily for 5 days, trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days, and fosfomycin trometamol 3g single dose, chosen based on local antibiogram 1, 6
  • For complicated UTI, obtain culture and susceptibilities BEFORE starting empiric therapy, then adjust based on results, and consider parenteral antibiotics for culture-resistant organisms 2, 5, 6

Recurrent UTI Management

  • For recurrent uncomplicated UTI (≥3 episodes in 12 months), document positive cultures with each symptomatic episode, and consider prevention strategies such as behavioral modifications, low-dose antibiotics, vaginal estrogen, and patient-initiated treatment 3, 5, 6

Microbiological Considerations

  • E. coli causes approximately 75-85% of all UTIs, both complicated and uncomplicated, and complicated UTIs more frequently involve Enterococcus faecalis, Proteus mirabilis, and other organisms 1, 2
  • Resistance patterns vary regionally, and antimicrobial selection should minimize impact on normal flora 6

Common Pitfalls to Avoid

  • Do NOT treat asymptomatic bacteriuria in non-pregnant, non-immunocompromised women, as it causes more harm than benefit 1, 5
  • Do NOT treat based on bacteria alone without pyuria, as this leads to overtreatment of contamination or colonization 5
  • Do NOT routinely perform imaging for uncomplicated recurrent UTI in the absence of risk factors 3, 7, 6
  • Do NOT use fluoroquinolones as first-line for uncomplicated UTI due to antimicrobial stewardship concerns 6

REFERENCES